In a recent study, a combination of CDK4/6 and mTOR inhibitors treatment showed a synergistic effect against iCCA tumor cell proliferation, but other CDK4/6 functions in transcription or differentiation independent of cell cycle processes reported recently remain [5, 19, 20]. This evidence concerns the gene MTOR and neoplasm.